Hepatic Hypoxia-Inducible Factor 1α Mediates Ferroptosis via Transferrin Receptor 1 in Acute Liver Injury
Antioxidants · 08.01.2026 · 15 (1) · 81
DOI: 10.3390/antiox15010081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 08.01.2026. Verfasst von Jiayu Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, C…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Shanghai Municipal Science and Technology committee of Shanghai outstanding academic leaders plan.
Abstract (Originalsprache)
Acute liver injury (ALI) is a potentially life-threatening condition lacking effective clinical drugs. Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of both inflammation and metabolism. In ALI, HIF-1α expressions are upregulated, but the role of HIF-1α in hepatocytes and whether it can be targeted remain unclear. Herein, clinical samples and ALI murine models including lipopolysaccharide/D-galactosamine (LPS/D-GalN), acetaminophen (APAP), and thioacetamide (TAA) revealed an increase in HIF-1α expression and ferroptosis. Using HIF-1α gain and loss of function mouse and hepatocyte culture models, we demonstrated that HIF-1α upregulation exacerbated liver ferroptosis and injury. Mechanistically, HIF-1α/transferrin receptor protein 1 (TFR1) axis drives hepatic iron overload, promoting ferroptotic cell death and liver injury. In addition, TFR1 inhibition reversed HIF-1α-induced ALI. Importantly, pharmacological inhibition of HIF-1α and TFR1 significantly reduced ferroptosis and mitigated liver injury both in vivo and in vitro. Together, our findings demonstrate the pathological role of hepatic HIF-1α, which may serve as a promising target of therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- State Key Laboratory of Drug Research, The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.
- State Key Laboratory of Drug Research, Ethnomedicine and Biofunctional Molecule Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
- Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
ORCID-Profile: Shichao Cui
Förderung
- the National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Shanghai Municipal Science and Technology committee of Shanghai outstanding academic leaders plan
- Shanghai "Science and Technology Innovation Action Plan" Biomedical Science and Technology Support Special Project
- the Shanghai “Science and Technology Innovation Action Plan” Biomedical Science and Technology Support Special Project
Zitieren
APA
Yang, J., Wang, M., Cui, S., Xia, Y., Xie, Y., Hu, Z., Li, N., Zhang, X., Zhu, P., Yu, X., Wu, L., & Li, J. (2026). Hepatic Hypoxia-Inducible Factor 1α Mediates Ferroptosis via Transferrin Receptor 1 in Acute Liver Injury. Antioxidants, 15(1), 81. https://doi.org/10.3390/antiox15010081
Vancouver
Yang J, Wang M, Cui S, Xia Y, Xie Y, Hu Z, et al. Hepatic Hypoxia-Inducible Factor 1α Mediates Ferroptosis via Transferrin Receptor 1 in Acute Liver Injury. Antioxidants. 2026;15(1):81. doi:10.3390/antiox15010081
BibTeX
@article{Yang2026,
author = {Yang, Jiayu and Wang, Meicheng and Cui, Shichao and Xia, Yulan and Xie, Yinfang and Hu, Zhu and Li, Ni and Zhang, Xinwen and Zhu, Pengfei and Yu, Xu and Wu, Linshi and Li, Jingya},
title = {Hepatic Hypoxia-Inducible Factor 1α Mediates Ferroptosis via Transferrin Receptor 1 in Acute Liver Injury},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {1},
pages = {81},
doi = {10.3390/antiox15010081}
}
EUVIMED